Leqembi (lecanemab-irmb)

$1,923.39

We can help with your prescription. Read the “Prescription Guide”.

You can access this medicine even if it’s not approved in your country. Learn how.

Leqembi (lecanemab-irmb) is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody that responds against the amyloid-beta (Aβ) plaques prescribed to treat patients with Alzheimer’s disease who present mild-stage cognitive impairment or dementia1.